GlassScriptPhysician profile
Michael Alexander Silva
NPI 1366856361
$3,702.47
in general payments reported to CMS, 2019-2025
37 companies · $735 in 2025
The $735 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.08 · 2020: $89.93 · 2021: $487 · 2022: $827 · 2023: $855 · 2024: $623 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,213.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $631.08 | 2020-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $392.23 | 2021-2025 | Ztlido |
| Medtronic, INC. | $371.66 | 2021-2025 | Intellis Adaptivestim, Pipeline, Kyphon Express II Kyphopak Tray |
| Balt USA, LLC | $300.11 | 2025 | Ballast 088 Long Sheath, Optima Coil System |
| Boston Scientific Corporation | $259.10 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $202.52 | 2021-2025 | Ubrelvy, Botox |
| Painteq LLC | $167.96 | 2021 | |
| Nevro Corp. | $156.90 | 2021-2023 | Senza |
| Abbott Laboratories | $155.28 | 2019-2023 | Proclaim |
| Saluda Medical Americas, INC. | $144.96 | 2025 | Evoke |
| Vgi Medical, LLC | $101.68 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.22 | 2023-2025 | Relistor |
| Grt US Holding, INC. | $78.22 | 2022 | |
| Stryker Corporation | $77.21 | 2023 | N/A |
| Forte Bio-Pharma LLC | $72.94 | 2022-2024 | Prolate, Nalocet |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $69.27 | 2024 | Horizant |
| Almatica Pharma LLC | $46.07 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.00 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $32.83 | 2022 | |
| Averitas Pharma INC. | $31.58 | 2023 | Qutenza |
| Vertos Medical, INC. | $25.68 | 2022 | |
| Allergan, INC. | $23.78 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $23.76 | 2022 | |
| Protega Pharmaceutials INC | $22.14 | 2023 | Roxybond |
| Spr Therapeutics, INC | $19.49 | 2022 | |
| Arbor Pharmaceuticals, INC. | $19.47 | 2020 | |
| Pfizer INC. | $17.36 | 2021 | |
| Radius Health, INC. | $16.48 | 2021 | |
| Ibsa Pharma INC. | $15.11 | 2021 | |
| Biofrontera INC. | $14.57 | 2021 | |
| Sonex Health, INC. | $14.52 | 2021 | |
| Curonix LLC | $14.47 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Electronic Waveform Lab, INC. | $13.86 | 2024 | |
| Redhill Biopharma INC. | $12.60 | 2021 | |
| Biodelivery Sciences International, INC. | $12.37 | 2021 | |
| Hikma Pharmaceuticals USA | $12.30 | 2022 | |
| Fidia Pharma USA INC. | $11.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.